FOOT AND MOUTH DISEASE VACCINE MARKET ANALYSIS

Foot And Mouth Disease Vaccine Market Size and Trends

Global foot and mouth disease vaccine market is estimated to be valued at USD 2.90 Bn in 2024 and is expected to reach USD 5.12 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.5 % from 2024 to 2031.

To learn more about this report, request sample copy

Huge presence of livestock and increasing demand for animal-derived food products can drive the market growth. The  supportive government initiatives to curb outbreaks of this highly contagious disease can also drive the market growth. Key market players are investing in research & development activities for developing effective foot and mouth vaccines. However, high costs associated with vaccine production and storage can hamper the market growth. The mitigation of huge economic losses due to FMD outbreaks can boost demand for foot and mouth disease vaccines.

Rise in cattle population

Global cattle population has been steadily increasing over the past few decades to meet rising demand for dairy and meat products. As cattle are highly susceptible to foot and mouth disease, growing number of cattle can raise  the risk of FMD outbreaks. Developing regions like Asia Pacific and Latin America that are witnessing a surge in livestock farming activities have emerged as major markets for FMD vaccines. Moreover, the commercialization of cattle rearing practices has led to clustering of cattle in large farms, which amplifies the spread of the disease. Controlling FMD epidemics through mass vaccination programs has become a priority for governments to minimize disruption in cattle trade and international movement of animals. This growing at-risk cattle population base leads to increased off-take and demand for effective FMD vaccines. In nations with substantial livestock populations like China and Mexico, the risk of infection is heightened. In September 2021, according to the Food and Agriculture Organization (FAO) Report, India's national cattle herd was 306.7 million animals in 2022, marking an increase of 1.2 million head from Italy's 2021 cattle count.

Heightened threat from new virus strains

Foot and mouth disease virus has a high mutation rate which allows new variants to evolve constantly. Emergence of novel strains that the existing vaccines may not offer protection against can pose a serious challenge. In recent years, unusual outbreaks caused by atypical FMD virus strains have been reported from parts of Asia, Africa and South America. For example, a virus type O pandemic strain affected huge cattle herds in countries like South Korea, Vietnam and Taiwan in 2010-2011 despite vaccination. Similarly, an unusual topotype of type A virus caused repeated epidemics in Middle East and North Africa since 2009  even in vaccinated cattle. Containing such rapidly evolving strains with cross-border spread capabilities requires continuous vaccine development and shortening of response times. This evolving epidemiological pattern boosts the need for enhanced surveillance of FMD viruses to design vaccines matching the circulating field strains more precisely.